Patient with Malignant Granular Cell Tumor Treated with Sunitinib Malate
Soonchunhyang Medical Science
;
: 66-69, 2012.
Artículo
en Coreano
| WPRIM
| ID: wpr-43356
ABSTRACT
Malignant granular cell tumors (MGST) are extremely rare, high-grade sarcoma of schwann cell origin. They often metastasize and are associated with short survival. We described a patient with recurred MGST after wide marginal excision followed by chemotherapy. The histologic findings revealed relapsed MGST containing rich vascular structure. The patient was treated with sunitinib malate (50 mg/day) for three weeks. Because sunitinib malate has a potent antiangiogenic property, we surmised that it might be effective against this type of malignancy. However, he died due to progression of tumor after six weeks. Here, we report it along with the corresponding literature.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pirroles
/
Sarcoma
/
Tumor de Células Granulares
/
Indoles
Límite:
Humanos
Idioma:
Coreano
Revista:
Soonchunhyang Medical Science
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS